8-K
Current Report
Cardiff Oncology, Inc. Filed Acc 0001321543-06-000104
Material agreement · Restatement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 4.02 Non-reliance on previously issued financial statements
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading maindoc.htm…